+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Imaging Biomarker"

Neurological Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Neurological Biomarkers - Global Strategic Business Report

  • Report
  • September 2026
  • 389 Pages
  • Global
From
From
Cancer Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Cancer Biomarkers - Global Strategic Business Report

  • Report
  • September 2026
  • 474 Pages
  • Global
From
From
Biomarker Development Pipeline Analysis, 2026 (Q2 Update) - Product Thumbnail Image

Biomarker Development Pipeline Analysis, 2026 (Q2 Update)

  • Report
  • August 2026
  • 182 Pages
  • Global
From
From
From
From
From
From
From
Hepatic Fibrosis Biomarkers Market - Product Thumbnail Image

Hepatic Fibrosis Biomarkers Market

  • Report
  • October 2025
  • 90 Pages
  • Global
From
From
Oncology Biomarkers: Global Markets - Product Thumbnail Image

Oncology Biomarkers: Global Markets

  • Report
  • June 2023
  • 186 Pages
  • Global
From
Biomarkers: Technologies and Global Markets 2021 - Product Thumbnail Image

Biomarkers: Technologies and Global Markets 2021

  • Report
  • March 2021
  • 216 Pages
  • Global
From
Loading Indicator

Imaging biomarkers are a type of biomarker used to measure and monitor biological processes in the body. They are used to detect and diagnose diseases, assess the effectiveness of treatments, and monitor the progression of diseases. Imaging biomarkers are typically used in conjunction with other biomarkers, such as genetic and molecular biomarkers, to provide a more comprehensive picture of a patient's health. Imaging biomarkers can be used to detect changes in the structure and function of organs, tissues, and cells. Examples of imaging biomarkers include MRI, CT, PET, and ultrasound. Imaging biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and radiology. They are also used in clinical trials to assess the safety and efficacy of new treatments. Imaging biomarkers are becoming increasingly important in the diagnosis and treatment of diseases, as they provide a more detailed picture of a patient's health. Companies in the imaging biomarker market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Systems. Show Less Read more